Checkpoint Inhibition and Cardiotoxicity: Cause for Concern? Checkpoint Inhibition and Cardiotoxicity: Cause for Concern?

A pharmacovigilance study reports four new cardiotoxicities in patients treated with immune checkpoint inhibitors. Experts say this should not deter physicians from offering these treatments to patients.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news